Skip to content

Neuroplasticity: all studies

Page 157 of 178: studies 1,561 to 1,570 of 1,773, newest first. Back to the neuroplasticity overview

Research

Changes in white matter in mice resulting from low-frequency brain stimulation.

Proceedings of the National Academy of Sciences July 3, 2018 Denise M Piscopo, Aldis P Weible, Mary K Rothbart et al.

Recent reports have begun to elucidate mechanisms by which learning and experience produce white matter changes in the brain. We previously reported changes in white matter surrounding the anterior cingulate cortex in humans after 2-4 weeks of meditation training. We further found that low-frequency optogenetic stimulation of the anterior cingulate in mice increased time spent in the light in a...

DOI: 10.1073/pnas.1802160115 (opens in new tab) Full text (opens in new tab) Meditation Anterior cingulate cortex Electron microscopy Mouse +1

The Boy Who Grew a New Brain: Understanding this Miracle from a Neuro-Quantum Perspective

NeuroQuantology June 26, 2018 Contzen Pereira 1 citation

In this paper, we present a case of a boy – Noah Wall, who till today surprises the world of neuroscience with his will to grow his brain and survive. The case presented in this study sets a stepping stone in understanding the advent of the will to make a choice, from a neuro-quantum mechanics interpretation. We propose that besides our internal states of choices (neurogenesis, neuroplasticity,...

Effects of a 7-Day Meditation Retreat on the Brain Function of Meditators and Non-Meditators During an Attention Task

Frontiers in Human Neuroscience June 11, 2018 Elisa H. Kozasa, Joana B Balardin, João R. Sato et al.

Meditation as a cognitive enhancement technique is of growing interest in the field of health and research on brain function. The Stroop Word-Color Task (SWCT) has been adapted for neuroimaging studies as an interesting paradigm for the understanding of cognitive control mechanisms. Performance in the SWCT requires both attention and impulse control, which is trained in meditation practices. We...

Delayed increase of thrombocyte levels after a single sub-anesthetic dose of ketamine - A randomized trial.

European Neuropsychopharmacology June 2018 Lejla Colic, Marie Woelfer, Merima Colic et al.

Recently, ketamine has been investigated as a potential antidepressant option for treatment resistant depression. Unlike traditional drugs, it yields immediate effects, most likely via increased glutamatergic transmission and synaptic plasticity. However, ketamine administration in humans is systemic and its long-term impact on blood parameters has not yet been described in clinical studies....

DOI: 10.1016/j.euroneuro.2018.03.014 (opens in new tab) Full text (opens in new tab) Delayed effect Human Sub–anesthetic ketamine Thrombocytes

Meditation-induced neuroplastic changes in amygdala activity during negative affective processing.

Social Neuroscience June 1, 2018 Mei-Kei Leung, Way K W Lau, Chetwyn C H Chan et al.

Recent evidence suggests that the effects of meditation practice on affective processing and resilience have the potential to induce neuroplastic changes within the amygdala. Notably, literature speculates that meditation training may reduce amygdala activity during negative affective processing. Nonetheless, studies have thus far not verified this speculation. In this longitudinal study,...

Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances.

Neuropsychopharmacology May 24, 2018 Oliver Vranjkovic, Garrett Winkler, Danny G Winder

Forced abstinence from chronic two bottle-choice ethanol drinking produces the development of negative affective states in female C57BL/6J mice. We previously reported that this disrupted behavior is acutely reversed by administration of ketamine 30 min-prior to testing. Here we assessed whether ketamine can be used as an inoculant against the development of abstinence- dependent affective...

Biphasic effects of THC in memory and cognition.

European journal of clinical investigation May 2018 Edward J Calabrese, Alberto Rubio-Casillas

A generally undesired effect of cannabis smoking is a reversible disruption of short-term memory induced by delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. However, this paradigm has been recently challenged by a group of scientists who have shown that THC is also able to improve neurological function in old animals when chronically administered at low...

DOI: 10.1111/eci.12920 (opens in new tab) Full text (opens in new tab) Cannabis Alzheimer's disease Biphasic dose response Delta-9-tetrahydrocannabinol +2

Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process

Frontiers in Pharmacology April 5, 2018 Antonio Inserra 91 citations

Ayahuasca ingestion modulates brain activity, neurotransmission, gene expression and epigenetic regulation. N,N-Dimethyltryptamine (DMT, one of the alkaloids in Ayahuasca) activates sigma 1 receptor (SIGMAR1) and others. SIGMAR1 is a multi-faceted stress-responsive receptor which promotes cell survival, neuroprotection, neuroplasticity, and neuroimmunomodulation. Simultaneously, monoamine...

DOI: 10.3389/fphar.2018.00330 (opens in new tab) Ayahuasca Memory consolidation Traumatic memories

Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.

Schizophrenia Research April 1, 2018 Susan Whitfield-Gabrieli, Adina S. Fischer, Angela Henricks et al.

Nearly half of patients with schizophrenia (SCZ) have co-occurring cannabis use disorder (CUD), which has been associated with decreased treatment efficacy, increased risk of psychotic relapse, and poor global functioning. While reports on the effects of cannabis on cognitive performance in patients with SCZ have been mixed, study of brain networks related to executive function may clarify the...

Mechanisms of Ketamine Action as an Antidepressant

Molecular Psychiatry March 13, 2018 Panos Zanos, T. Gould 1,112 citations

Clinical studies have demonstrated that a single sub-anesthetic dose of the dissociative anesthetic ketamine induces rapid and sustained antidepressant actions. Although this finding has been met with enthusiasm, ketamine’s widespread use is limited by its abuse potential and dissociative properties. Recent preclinical research has focused on unraveling the molecular mechanisms underlying the...